1. Home
  2. ANY vs RNAZ Comparison

ANY vs RNAZ Comparison

Compare ANY & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere 3D Corp.

ANY

Sphere 3D Corp.

HOLD

Current Price

$1.67

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$10.83

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANY
RNAZ
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ANY
RNAZ
Price
$1.67
$10.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$30.00
$280.00
AVG Volume (30 Days)
94.0K
614.6K
Earning Date
03-27-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,099,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$29.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$6.08
52 Week High
$12.60
$357.56

Technical Indicators

Market Signals
Indicator
ANY
RNAZ
Relative Strength Index (RSI) 91.87 58.15
Support Level $0.16 $7.99
Resistance Level $0.26 $12.30
Average True Range (ATR) 0.06 1.44
MACD 0.09 0.01
Stochastic Oscillator 85.41 61.81

Price Performance

Historical Comparison
ANY
RNAZ

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: